A popular sedative has recently been linked with an increased risk of developing Alzheimer's disease. Benzodiazepines, which are used to treat anxiety and insomnia, are associated with a heightened risk of developing the condition, a new study claims. Published on the British Medical Journal (bmj.com) , it examined data from a health insurance database in Quebec.
French and Canadian researchers identified 1,700 elderly people with Alzheimer's disease and more than 7,000 healthy people for comparison. The use of benzodiazepines was associated with an increased risk of actually developing the disease. The risk was greatest among those who used the long-acting version of the medication.
_____________________________________________________________________________________________________________________
No comments:
Post a Comment